Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe

被引:90
作者
Zhao, YQ
Cao, JA
OGorman, MRG
Yu, M
Yogev, R
机构
[1] CHILDRENS MEM HOSP,DIV INFECT DIS,SECT PEDIAT & MATERNAL HUMAN IMMUNODEFICENCY VIRU,CHICAGO,IL 60614
[2] NORTHWESTERN UNIV,SCH MED,DEPT PEDIAT,CHICAGO,IL 60611
关键词
D O I
10.1128/JVI.70.9.5821-5826.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) Vpr protein affects cell morphology and prevents proliferation of human cells by induction of cell cycle G(2) arrest. In this study, we used the fission yeast Schizosaccharomyces pombe as a model system to investigate the cellular effects of HIV-1 vpr gene expression, The vpr gene was cloned into an inducible fission yeast gene expression vector and expressed in wild-type S, pombe cells, and using these cells, we were able to demonstrate the specific Vpr induced effects by induction and suppression of vpr gene expression. Induction of HIV-1 vpr gene expression affected S, pombe at the colonial, cellular, and molecular levels, Specifically, Vpr induced small-colony formation, polymorphic cells, growth delay, and cell cycle G(2) arrest. Additionally, Vpr-induced G(2) arrest appeared to be independent of cell size and morphological changes. The cell cycle G(2) arrest correlated with increased phosphorylation of p34(cdc2), suggesting negative regulation of mitosis by HIV-1 Vpr, Treatment of Vpr-induced cells with a protein phosphatase inhibitor, okadaic acid, transiently suppressed cell cycle arrest and morphological changes, This observation implicates possible involvement of protein phosphatase(s) in the effects of Vpr, Together, these data showed that the HN-1 Vpr-induced cellular changes in S. pombe are similar to those observed in human cells, Therefore, the S, pombe system is suited for further investigation of the HIV-1 vpr gene functions.
引用
收藏
页码:5821 / 5826
页数:6
相关论文
共 36 条
[1]  
ALFA C, 1993, EXPT FISSION YEAST L, P52
[2]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[3]   TATA BOX MUTATIONS IN THE SCHIZOSACCHAROMYCES-POMBE NMT-1 PROMOTER AFFECT TRANSCRIPTION EFFICIENCY BUT NOT THE TRANSCRIPTION START POINT OR THIAMINE REPRESSIBILITY [J].
BASI, G ;
SCHMID, E ;
MAUNDRELL, K .
GENE, 1993, 123 (01) :131-136
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[5]   ISOLATION AND CHARACTERIZATION OF CDNA CLONES ENCODING A FUNCTIONAL P34CDC2 HOMOLOG FROM ZEA-MAYS [J].
COLASANTI, J ;
TYERS, M ;
SUNDARESAN, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3377-3381
[6]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[7]  
FANTES PA, 1977, J CELL SCI, V24, P51
[8]   A PRE-START CHECKPOINT PREVENTING MITOSIS IN FISSION YEAST ACTS INDEPENDENTLY OF P34(CDC2) TYROSINE PHOSPHORYLATION [J].
HAYLES, J ;
NURSE, P .
EMBO JOURNAL, 1995, 14 (12) :2760-2771
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRAL-PROTEIN-R (VPR) ARRESTS CELLS IN THE G(2) PHASE OF THE CELL-CYCLE BY INHIBITING P34(CDC2) ACTIVITY [J].
HE, JL ;
CHOE, S ;
WALKER, R ;
DIMARZIO, P ;
MORGAN, DO ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6705-6711
[10]   THE VPR PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFLUENCES NUCLEAR-LOCALIZATION OF VIRAL NUCLEIC-ACIDS IN NONDIVIDING HOST-CELLS [J].
HEINZINGER, NK ;
BUKRINSKY, MI ;
HAGGERTY, SA ;
RAGLAND, AM ;
KEWALRAMANI, V ;
LEE, MA ;
GENDELMAN, HE ;
RATNER, L ;
STEVENSON, M ;
EMERMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7311-7315